Aug 29, 2025 3-5pm ET
Friday on The Robert Scott Bell Show:
Hour 1
Follow the Scientism Aaron Kheriaty argues that the COVID-19 crisis revealed a troubling shift in Western societies toward scientism—the elevation of science into a dogmatic ideology that excludes debate and functions as an ersatz religion. He documents how Australia and Canada built detention facilities for asymptomatic or exposed citizens, and how medical authorities such as Australia’s MIPS effectively forbade doctors from sharing peer-reviewed findings if they conflicted with official messaging. In the United States, the Federation of State Medical Boards and California’s AB 2098 codified similar measures, threatening physicians with license loss for contradicting consensus views on COVID, even as consensus statements were already outdated. Kheriaty insists that real science thrives on conjecture, refutation, and open debate, whereas scientism suppresses dissent, conflates consensus with truth, and fosters authoritarian control of speech. Drawing on the philosophy of Augusto Del Noce, he explains that technocratic societies rooted in scientism deny transcendent truths, reduce humans to biological raw material, and monopolize what counts as rationality, silencing moral, metaphysical, or religious claims as meaningless. This ideological rigidity, he contends, mirrors totalitarian methods by enforcing conformity not through brute force but through censorship, slander, and exclusion from public discourse. During COVID, qualitative goods like family, worship, and community were sacrificed to quantitative biomedical goals, reflecting scientism’s upside-down priorities. Kheriaty concludes that this worldview leaves individuals isolated, uprooted, and manipulable, while opening the door to domination by corporations and political elites. Unlike genuine science, which is provisional and humble, scientism embodies hubris and nihilism, advancing a utopian myth of progress that destroys tradition and undermines human flourishing.
Special Guest: Inesa Ponomariovaite
Inesa Ponomariovaite, the founder of Nesa’s Hemp, is a visionary leader with a profound commitment to holistic health. Growing up in a working-class family in Lithuania, Inesa began working at the age of 10 to support her family, eventually taking on the responsibility of caring for her siblings. As a young adult, she moved to the United States, where she faced severe health challenges and domestic violence, which left her hospitalized and homeless. Demonstrating remarkable resilience, Inesa rebuilt her life through sheer determination and hard work. Her journey to health led her to transition from relying on pharmaceuticals to embracing natural foods and exercise, ultimately restoring her well-being.
Inesa’s passion for holistic health was further ignited by her mother’s cancer diagnosis, prompting her to explore the potential of CBD. Through extensive research and collaboration with experts worldwide, she discovered that many existing CBD products were of substandard quality. Determined to create a superior product, Inesa founded Nesa’s Hemp, which produces the world’s first full-spectrum CBDa Hemp Oil. Her products are meticulously crafted to be 100% natural and free from chemicals, solvents, and heavy metals. Inesa’s mission is to change the world by helping people harness the healing power of nature, promoting well-being in body, mind and spirit.
Common Painkillers May Fuel Deadly Superbugs That Resist Antibiotics, Study Warns A new study led by the University of South Australia indicates that widely used over-the-counter painkillers—specifically ibuprofen and acetaminophen—may significantly contribute to the growing crisis of antibiotic resistance, a problem responsible for an estimated 4.95 million deaths annually. In laboratory experiments, researchers exposed Escherichia coli (E. coli) to the antibiotic ciprofloxacin both alone and in combination with these painkillers. While ciprofloxacin on its own triggered some genetic changes, the addition of ibuprofen or acetaminophen dramatically increased the rate of bacterial mutations, leading not only to resistance against ciprofloxacin but also to other antibiotic classes. The study reveals that these painkillers activate bacterial defense mechanisms that enhance the ability to expel drugs, enabling faster bacterial growth and greater resistance. The findings are particularly troubling in aged care environments, where polypharmacy—residents taking multiple medications simultaneously—is common; the study tested nine representative drugs used in such settings and found ibuprofen and acetaminophen to be the most significant offenders. While the researchers explicitly do not advise stopping these painkillers, they stress the urgent need for increased awareness about their potential interactions with antibiotics. This underscores a broader insight: antibiotic resistance isn’t solely driven by antibiotic misuse—it also arises from unintended drug interactions, particularly in settings where frail populations routinely take multiple medications. The study, published in the journal Antimicrobials and Resistance, underscores the critical need for further investigation into how non-antibiotic medications may undermine antibiotic efficacy.
Welcome to another Homeopathic Hits segment on The Robert Scott Bell Show!
On The Robert Scott Bell Show today, we look at Lycopersicum Esculentum—the common tomato in its potentized form.
While the crude plant can cause irritation and digestive disturbance, in homeopathy it becomes a unique remedy for rheumatic pains, headaches, and sluggish digestion, especially when symptoms worsen in damp weather or from overexertion.
Download the Information Sheet
Hour 2
Cassidy Calls for Vaccine Committee Meeting to be Postponed Following CDC Departures Senator Bill Cassidy, M.D., chair of the Senate HELP Committee, has issued a call to indefinitely postpone the September 18 meeting of the Advisory Committee on Immunization Practices (ACIP) amid unprecedented turmoil at the Centers for Disease Control and Prevention. He cited serious concerns over the meeting’s agenda, the qualifications and composition of its membership, and a broader breakdown in the scientific process—recent upheaval at the CDC includes the abrupt dismissal of Director Susan Monarez and mass resignations of senior officials in protest of politically driven vaccine policy changes. Cassidy stressed that any recommendations emerging from a compromised panel should be considered illegitimate, arguing that children’s health and well-being are at stake. His warning comes after earlier attempts to delay the panel’s meetings were similarly motivated by the appointment of a new cadre of ACIP members lacking relevant expertise, many aligned with anti-vaccine sentiments. The senator’s latest demand underscores growing bipartisan concern over the erosion of scientific integrity within federal health institutions and raises pressing questions about the legitimacy of vaccine policy made under such fraught conditions.
Special Guest: Dr. Jason Dean
Dr. Jason Dean is a Husband, Father, and Doctor Calling out Medical & Pharma Cartels. Dr. Dean is best known for helping people reverse chronic health issues. For 19 years Dr. Dean and his wife have operated Palmer Natural Health, the largest Nutrition & Chiropractic office in the World, utilizing whole food nutrition and Quantum Nutrition. Dr. Dean is the Creator and Host of BraveTV.com and the Owner of Revolution Health. BraveTV is a media and content channel for Restoring the American Republic. This is done through the education of Health Freedom, Constitutional learning and maximizing Knowledge.
Big Pharma Companies Paid 80% Of Multiple Sclerosis Doctors $164 Million Over 5 Years Between 2015 and 2019, nearly 80 percent of U.S. neurologists treating patients with multiple sclerosis received a combined total of approximately $164 million in general industry payments—spanning meals, consulting fees, travel, and honoraria—from pharmaceutical companies, according to a retrospective cohort study published in BMJ Open. Specifically, 5,809 of the 7,401 neurologists analyzed (78.5 percent) received at least one payment, totaling $163.6 million in 626,290 discrete transactions; notably, the top 10 percent of recipients accounted for 95 percent of the total payout, indicating a highly targeted distribution focused on high-volume prescribers. The analysis also revealed a clear correlation between payment amounts and prescribing behavior: neurologists were more likely to prescribe drugs from companies that paid them, especially when payments were recent, prolonged, or large. Even modest sums were associated with increased prescribing—e.g., $50 corresponded to a 10 percent higher likelihood of prescribing that company’s drugs, rising to 50 percent for $5,000. Physicians who received payments in consecutive years were up to 78 percent more likely to prescribe those companies’ medications compared to unpaid peers. These findings raise concerns about the influence of promotional efforts in shaping clinical decision-making, particularly in the wealthy and competitive MS medication market, and invite scrutiny over potential conflicts of interest that may drive prescriptions beyond evidence-based appropriateness.
Remember Friends, The Power to Heal is Yours!
